glp-1 receptor agonist antipsychotic weight gain study New Loss Drugs in Psychiatry Antipsychotic-Induced Weight Gain in Severe

doi: 10.1007/S13577-024-01038-1/FIGURES/8 85 KapoorISarvepalliSMDAlessioDGrewalDSHadziahmetovicM

Moreover, worsening glycemic control escalates the likelihood of AP (Wolfe et al., 2020)

Int J Mol Sci (2023) 24(4):3140

As a result, the safety and tolerability profile of retatrutide aligns with other incretin-based therapies (hormones produced by the gut that help regulate blood sugar levels)

If we conflate access to drugs with access to quality multidisciplinary care, were going down the wrong path altogether

cAMP signaling stimulates PKA and EPAC, both of which contribute to the production and release of insulin (Yang and Yang, 2016)